Sienna Biopharmaceuticals, Inc.·4

Jul 3, 1:47 PM ET

Stroehmann Diane 4

4 · Sienna Biopharmaceuticals, Inc. · Filed Jul 3, 2019

Insider Transaction Report

Form 4
Period: 2019-07-02
Stroehmann Diane
See Remarks
Transactions
  • Tax Payment

    Common Stock

    2019-07-02$0.76/sh4,095$3,112168,545 total
Footnotes (3)
  • [F1]Represents shares otherwise issuable to the Reporting Person that were withheld to satisfy the Issuer's tax withholding obligation upon settlement of restricted stock units.
  • [F2]This transaction was executed in multiple trades in prices ranging from $0.72 to $0.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]Includes a total of 2,916 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT